Tag: Abolis
-
35 million euro for sustainable biotech: International consortium invests into Abolis Biotechnologies
35 million euro for sustainable biotech: International consortium invests into Abolis Biotechnologies Évry-Courcouronnes, September 12, 2024 – Abolis Biotechnologies, a company specializing in industrial solutions using microorganisms, today announced the closing of a €35 million financing round led by an international consortium of investors. This funding will fuel the company’s expansion into global markets and […] … weiterlesen